Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Biocartis Group NV    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société BIOCARTIS GROUP NV
11/24BIOCARTIS : Disclosure of a transparency notification
PU
11/24PRESS NEWS BIOCARTIS GROUP NV - REGU : Disclosure of a transparency notification
AQ
11/17BIOCARTIS : Announces Publication of Large Multi-Center Comparison Study with Id..
PU
11/17PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Publication of Large Multi-C..
AQ
11/16BIOCARTIS : Announces Ten Idylla™ Studies to be Published at Virtual AMP (..
PU
11/16PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Ten Idylla™ Studies t..
AQ
11/12BIOCARTIS : Q3 2020 business update
PU
11/12PRESS NEWS BIOCARTIS GROUP NV : Biocartis q3 2020 business update
AQ
11/10PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces CE-marking of its Fully Auto..
AQ
11/03BIOCARTIS : Announces Partnership with Endpoint Health to Develop Novel Companio..
PU
11/03BIOCARTIS : and GeneproDx To Collaborate on Fully Automated ThyroidPrint® test o..
PU
11/03PRESS NEWS BIOCARTIS GROUP NV : Biocartis and GeneproDx To Collaborate on Fully..
AQ
11/03PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Partnership with Endpoint He..
AQ
10/29PRESS NEWS BIOCARTIS GROUP NV : Biocartis and Exact Sciences Agree to End Collab..
AQ
10/29PRESS NEWS BIOCARTIS GROUP NV : Update on the partnership with Exact Sciences
AQ
10/06PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Market Release of SeptiCyte..
AQ
09/30CORPORATE STATEMENT : Biocartis Joins COVID-19 Testing Industry Consortium of Ni..
PU
09/30PRESS NEWS BIOCARTIS GROUP NV : Biocartis Receives EUR 1.2 million Grant for Dev..
AQ
09/25BIOCARTIS : Results of the Extraordinary Shareholders' Meeting held on 25 Septem..
PU
09/25PRESS NEWS BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Meeti..
AQ
09/14BIOCARTIS : Large Prospective Lung Cancer Study To Be Presented at ESMO Congress..
PU
09/14BIOCARTIS : Large Prospective Lung Cancer Study To Be Presented at ESMO Congress..
AQ
09/04PRESS NEWS BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders' Me..
AQ
09/03PRESS NEWS BIOCARTIS GROUP NV : Biocartis announces h1 2020 results
AQ
09/02PRESS NEWS BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Meeti..
AQ
09/01PRESS NEWS BIOCARTIS GROUP NV : Biocartis Expands Collaboration with LifeArc
AQ
08/27BIOCARTIS : announces 2020 half-year results on 3 September 2020
PU
08/27BIOCARTIS : Announces 2020 half-year results on 3 september 2020
AQ
08/26BIOCARTIS : Invitation to the Extraordinary Shareholders' Meeting
PU
07/31PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders'..
AQ
06/26PRESS RELEASE BIOCARTIS GROUP NV : US Multicenter Study Shows Idylla™ Allo..
AQ
05/08PRESS RELEASE BIOCARTIS GROUP NV : Results of the Shareholders' Meetings held on..
AQ
04/30PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Creates New Share Option Plan
AQ
04/23PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Q1 2020 Business Update
AQ
04/23PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Development of Idylla&tr..
AQ
04/21BIOCARTIS GROUP NV : Important Notice Regarding the Annual and Extraordinary Sha..
AQ
04/20PRESS RELEASE BIOCARTIS GROUP NV : Important Notice Regarding the Annual and Ext..
AQ
04/07PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Annual and Extraordinary Sh..
AQ
04/02PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Publication of 2019 Annua..
AQ
03/26BIOCARTIS : Announces Co-Commercialization of the SeptiCyte® RAPID Test on Idyll..
AQ
03/05BIOCARTIS : Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aime..
AQ
03/05PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2019 results and 2020 out..
AQ
03/05PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Creates New Share Option Plan & Can..
AQ
02/27PRESS RELEASE BIOCARTIS GROUP NV : Biocartis to Host Webcast for Announcement 2..
AQ
01/27PRESS RELEASE BIOCARTIS GROUP : Biocartis announces resignation cfo
AQ
01/22PRESS RELEASE BIOCARTIS GROUP : Biocartis Enters into Master Collaboration Agree..
AQ
01/09BIOCARTIS : Meets 2019 Key Business Objectives
AQ
01/09PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Meets 2019 Key Business Objectives
AQ
2019PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces 2020 Financial Calendar
AQ
2019PRESS RELEASE BIOCARTIS NV : Disclosure of a transparency notification
AQ
2019PRESS NEWS BIOCARTIS GROUP NV : Disclosure of a transparency notification
AQ
2019BIOCARTIS GROUP NV : Disclosure of transparency notifications
GL
2019BIOCARTIS GROUP NV : Disclosure of a transparency notification
GL
2019BIOCARTIS GROUP NV : Idylla(TM) MSI Performance Study Selected for Publication a..
GL
2019BIOCARTIS GROUP NV : Results of the annual shareholders' meeting held on 10 May ..
GL
2019BIOCARTIS GROUP NV : Biocartis announces final terms of its eur 150 million seni..
GL
2019BIOCARTIS GROUP NV : Biocartis announces successful placement of eur 150 million..
GL
2019BIOCARTIS GROUP NV : Biocartis launches convertible bonds offering of eur 125 mi..
GL
2019BIOCARTIS GROUP NV : Biocartis q1 2019 business update
GL
2019BIOCARTIS GROUP NV : Invitation to Annual Shareholders' Meeting
GL
2019BIOCARTIS GROUP NV : Disclosure of outstanding voting securities
GL
2019BIOCARTIS GROUP NV : Biocartis announces publication of its 2018 annual report
GL
2019BIOCARTIS GROUP NV : Biocartis and Bristol-Myers Squibb Sign Collaboration Agree..
GL
2019BIOCARTIS GROUP NV : Biocartis announces CE-IVD marking of its Idylla(TM) MSI Te..
GL
2019BIOCARTIS GROUP NV : Biocartis announces 2018 results and 2019 outlook
GL
2019BIOCARTIS GROUP NV : Biocartis Places Its 1,000th Idylla(TM) Instrument with Gei..
GL
2019BIOCARTIS GROUP NV : Disclosure of a transparency notification
GL
2019BIOCARTIS GROUP NV : Disclosure of a transparency notification
GL
2019BIOCARTIS GROUP NV : Biocartis successfully raises eur 55.50 million
GL
2019BIOCARTIS GROUP NV : Biocartis upsizes its equity placement due to significant d..
GL
2019BIOCARTIS GROUP NV : Biocartis launches equity placement
GL
2019BIOCARTIS : Announces Achieving its 2018 Key Business Objectives
PU
2019BIOCARTIS : and Nichirei Bioscience Announce Commercialization Collaboration for..
PU
2019BIOCARTIS : Corporate Presentation
PU
2019BIOCARTIS GROUP NV : Biocartis Announces Achieving its 2018 Key Business Objecti..
GL
1  2  3  4  5Next
Upcoming event on BIOCARTIS GROUP NV